Phoenix, Arizona–(Newsfile Corp. – June 5, 2023) – The Stock Day Podcast invited BioLargo, Inc. (OTCQB: BLGO), a cleantech and life sciences innovator and engineering services service service provider. President and CEO of BioLargo, Inc., Dennis P. Calvert, signed up with Stock Day host Kevin Davis.
The interview covered the following subjects:
-
The business’s very first quarter monetary outcomes, consisting of increased earnings from sales of private-label animal smell item Pooph (www.pooph.com),
-
Progress at the business’s engineering group,
-
Progress at subsidiary Clyra Medical and its Bioclynse surgical injury watering service,
-
The business’s general innovation advancement cycle; and
-
The business’s sodium-sulfur battery innovation.
“What we’re going to witness, our company believe, is precisely what’s taking place at Pooph has the prospective to take place for all the other running possessions in the portfolio,” said Mr. Calvert. “In each case, we have actually done the hardest work to create, show up, discover very first industrial adoption, and after that discover circulation through collaborations.”
To hear Dennis Calvert’s whole interview, follow the link to the podcast here: https://audioboom.com/posts/8312041-biolargo-inc-discusses-record-breaking-financial-results-innovation-pipeline-business-model-a.
Investors Hangout is a happy sponsor of “Stock Day,” and Stock Day Media motivates listeners to go to the business’s message board at https://investorshangout.com/.
About The “Stock Day” Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap business. It informs financiers while all at once dealing with cent stock and OTC business, offering openness and information of under-valued, under-sold Micro-Cap stocks of the marketplace. Stock Day supplies business with personalized services to their news circulation in both nationwide and worldwide media outlets. The Stock Day Podcast is the top radio program of its kind in America.
SOURCE:
Stock Day Media
(602) 821-1102
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) is a cleantech and life sciences innovator and engineering services service service provider. Its core items deal with PFAS contamination, attain sophisticated water and wastewater treatment, control smell and VOCs, enhance air quality, and control infections and contagious illness. Its business technique is to create or get unique innovations, establish them into item offerings, and extend their industrial reach through licensing and channel collaborations to optimize their effect. www.BioLargo.com
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This news release includes positive declarations within the significance of the Private Securities Litigation Reform Act of 1995. These positive declarations consist of without restriction those about BioLargo’s (the “Company”) expectations concerning awaited profits and prepare for future operations, and might be determined by words such as “our company believe”. These declarations include threats and unpredictabilities, and real outcomes might vary materially from any future outcomes revealed or indicated by the positive declarations. Risks and unpredictabilities consist of without restriction: the impact of the COVID-19 pandemic on the Company’s business, outcomes of operations, monetary condition, and stock cost; the impact of international and local financial conditions on the Company’s business, consisting of results on buying choices by customers and businesses; the capability of the Company to contend in markets that are extremely competitive and based on quick technological modification; the capability of the Company to handle regular intros and shifts of product or services, consisting of providing to the market, and promoting consumer need for, brand-new items, services, and technological developments on a prompt basis; the dependence of the Company on the efficiency of suppliers of the Company’s items. More details on these threats and other prospective elements that might impact the Company’s business and monetary outcomes is consisted of in the Company’s filings with the SEC, consisting of in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” areas of the Company’s most just recently submitted routine reports on Form 10-K and Form 10-Q and subsequent filings. The Company presumes no commitment to update any positive declarations or details, which speak since their particular dates.
To see the source variation of this news release, please see
